GENFLOW BIOSCIENCES PLC (GENFF)
GENFF moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How GENFF actually reacts to news — the realized, point-in-time move the market made, measured across 80 labeled events over the last three years with zero look-ahead.
GENFF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 0% | 17 |
| 30-min | 0.00% | 6% | 17 |
| 60-min | 0.00% | 6% | 17 |
| to close | 0.00% | 6% | 17 |
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GENFF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GENFF's baseline. Nothing else.
Recent GENFF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Genflow Biosciences PLC Announces Corporate Update | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Presentation of Interim Results | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | +0.00% | |
| Genflow Biosciences PLC Announces Half-year Financial Report | Press release | ACCESS Newswire | -25.09% | -25.09% | |
| Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Patent Update | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Result of AGM | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Participation at BIO International Convention 2026 | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026 | Press release | ACCESS Newswire | -46.15% | -46.15% | |
| Genflow Biosciences PLC Announces Notice of AGM | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Final Results | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Expansion of Confidentiality Agreements | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Strategic Technology Collaboration | Press release | ACCESS Newswire | +0.00% | -12.50% | |
| Genflow Biosciences PLC Announces International Patent Publication | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Total Voting Rights | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Issue of Equity & PDMR Notifications | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Receipt of First Tranche of Grant | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Result of GM | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Notice of GM | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Holding(s) in Company | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Directorate Change | Press release | ACCESS Newswire | — | — | |
| Genflow Completes Dosing Phase of Canine Gene Therapy Trial | Press release | ACCESS Newswire | — | — | |
| Genflow to Attend Healthcare Conference | Press release | ACCESS Newswire | +0.00% | -37.76% | |
| Genflow Biosciences PLC Announces Total Voting Rights | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Holding(s) in Company | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Second European Patent Application | Press release | ACCESS Newswire | +0.00% | -49.46% | |
| Genflow Biosciences PLC Announces Recognition of Patentability of Claims | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Update on Animal Health Program | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification | Press release | ACCESS Newswire | +0.00% | +100.00% | |
| Correction - Genflow Biosciences PLC Announces Issue of Equity | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Issue of Equity | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Half-Year Report | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Holding(s) in Company | Press release | ACCESS Newswire | — | — | |
| Genflow Strengthens IP Portfolio | Press release | ACCESS Newswire | — | — | |
| Genflow Signs CDAs with Animal Health Companies | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Company Update on Dog Trials | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Clinical Readiness Acceleration | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Confirms Progression of Grant | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences PLC Announces Corporate Update | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Genflow Biosciences and CER Sign Master Service Agreement to Strengthen Long-Term R&D Collaboration | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces AGM Notice | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Key SIRT6 Patent Application | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Holding(s) in Company | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update | Press release | ACCESS Newswire | — | — | |
| Genflow Biosciences PLC Announces Final Results | Press release | ACCESS Newswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GENFF section they belong to.
Where else GENFF is measured.
GENFF earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is GENFLOW BIOSCIENCES PLC's median reaction calculated?
Every labeled GENFF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 80 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 6% of GENFF's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GENFF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.